Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model.

Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model.

Item
http://www.wikidata.org/entity/Q35798966
Combined VEGFR and CTLA-4 blockade increases the antigen-presenting function of intratumoral DCs and reduces the suppressive capacity of intratumoral MDSCs.Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion.Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma.Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma.The FDA approved PI3K inhibitor GDC-0941 enhances in vitro the anti-neoplastic efficacy of Axitinib against c-myc-amplified high-risk medulloblastoma.Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma.Maintaining unperturbed cerebral blood flow is key in the study of brain metastasis and its interactions with stress and inflammatory responses.Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma.Combinatorial effects of VEGFR kinase inhibitor axitinib and oncolytic virotherapy in mouse and human glioblastoma stem-like cell models.The role of tumor microenvironment in resistance to anti-angiogenic therapy.Second-Line Treatment Landscape for Renal Cell Carcinoma: A Comprehensive Review.Targeting VEGF/VEGFR to Modulate Antitumor Immunity.Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer TherapyTurn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression
P2860

Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model.

Item
http://www.wikidata.org/entity/Q35798966
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Axitinib increases the infiltr ...... acranial mouse melanoma model.
@ast
Axitinib increases the infiltr ...... acranial mouse melanoma model.
@en
type
label
Axitinib increases the infiltr ...... acranial mouse melanoma model.
@ast
Axitinib increases the infiltr ...... acranial mouse melanoma model.
@en
prefLabel
Axitinib increases the infiltr ...... acranial mouse melanoma model.
@ast
Axitinib increases the infiltr ...... acranial mouse melanoma model.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Axitinib increases the infiltr ...... racranial mouse melanoma model
@en
P2093
P2860
P304
P31
P356
10.1080/2162402X.2014.998107
P433
P478
P50
P577
P5875
P698
P932